Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page
- CheckyesterdayChange DetectedThe page's study record dates were updated to reflect new postings and milestones: new dates (2026-09-08, 2026-09-02, 2026-08, 2032-11-21) were added and older dates (2025-12-03, 2032-11-30, 2025-12-02, 2025-11) were removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMelanoma and MedlinePlus Genetics were added to the related topics. The site revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a small update to the page content or backend system.SummaryDifference0.0%

- Check50 days agoChange Detected- Revision: v3.6.4 updated from v3.6.3 to reflect a newer page template release. This change does not modify the study content or how the study details are presented.SummaryDifference0.0%

- Check58 days agoChange DetectedA new publication citation has been added to the Publications section, documenting a 5-year update of KEYNOTE-942 in J Clin Oncol (2026). This expands the study's listed references to reflect longer-term results.SummaryDifference0.0%

- Check65 days agoChange DetectedRemoved the Melanoma topic, the related topics heading, and the MedlinePlus Genetics link from the page. This changes the navigational context and reduces access to disease-related information on the study page.SummaryDifference0.1%

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.